Novo Nordisk invests $2.3 billion in Danish production facility
COPENHAGEN (Reuters) -Danish drugmaker Novo Nordisk will invest 15.9 billion Danish crowns ($2.29 billion) to expand a production facility in Denmark for products to treat serious chronic diseases, the company said in a statement on Monday. The existing facility produces active pharmaceutical ingredient (API), the main biologically active components of medicines, and will be expanded to produce material for both current and future products. The expansion is not for the […]